Emprint Ablation Visualization Application
by Covidien llc
510(k) K180192
Active
Valid until
No expiry
FDA recalls
None found
Documents
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK180192 | Date21 Mar 2018 | StatusActive |
Official records
- FDA 510(k) database K180192
From the FDA record
- Received by the FDA
- 24 Jan 2018
- FDA decision
- 21 Mar 2018 (Substantially Equivalent)
- FDA review time
- 56 days from receipt to decision
- Public document
- 510(k) summary on file with the FDA
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- LLZ
- FDA applicant
- Covidien, LLC
- Device class
- Class II
- Regulation
- 21 CFR Part 892.2050
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The Emprint Ablation Visualization Application is a software tool classified as a medical imaging software (Product Code: LLZ) under FDA guidelines. It is designed to assist in the visualization and planning of ablation procedures, enabling clinicians to map and monitor ablation zones in real time. By integrating with imaging systems, it enhances precision during microwave ablation treatments, supporting targeted tissue removal or destruction. The application aids in improving procedural accuracy and safety by providing detailed spatial data of the treatment area.
This application is supplied as a digital tool for use with compatible ablation systems and imaging platforms, requiring no physical sterilization or single-use considerations. It operates within standard clinical environments, including radiology suites, and is intended for use by trained professionals. The software does not require specific regulatory classifications beyond its FDA 510(k) clearance under the Radiology Advisory Committee (RA). No physical storage or sterility requirements apply, as it is a software-based solution deployed on compatible devices. Compliance is governed by the original FDA clearance (K180192) and applicable software validation standards.
Devices cleared under K180192
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| Emprint CAVA | CAVA | 10884521783928 | — | On the market |
| Emprint CAVA | CAVA | 10884521717411 | — | On the market |
Similar devices
Other devices filed under FDA product code LLZ (System, Image Processing, Radiological).
- Amicas Light Beam Workstation Model 1.0 by Amicas, Inc.
- Amalga PACS by Global Care Solutions, S.A.
- RI.HIP MODELER by Blue Belt Technologies, Inc.
- Xeleris 3.1 Processing and Review Workstation by Ge Medical Systems F.I. Haifa
- Quantim 2000I Digital Image Analysis System by Quantitative Cardiac Systems (Qcs), Inc.
- PATXFER by Brainlab AG
- BrainSpec Core Software by BRAINSPEC, INC
- MEDIPACS by Neobit Co., Ltd.
- Syngo Multimodality Workplace (Syngo MM WP) by Siemens Medi Cal Solutions, Inc.
- Heartlab Cardiovascular by Heartlab, Inc.